Download PDF
Digestive Disease Interventions 2020; 04(01): 013-018
DOI: 10.1055/s-0040-1705094
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Role of Liver Transplantation for Liver Metastasis from Colorectal Cancer

Koji Tomiyama
1   Division of Abdominal Transplantation, University of Rochester Medical Center, Rochester, New York
,
M. Katherine Dokus
1   Division of Abdominal Transplantation, University of Rochester Medical Center, Rochester, New York
,
Jennie Errigo
1   Division of Abdominal Transplantation, University of Rochester Medical Center, Rochester, New York
,
Marie Laryea
1   Division of Abdominal Transplantation, University of Rochester Medical Center, Rochester, New York
,
Roberto Hernandez-Alejandro
1   Division of Abdominal Transplantation, University of Rochester Medical Center, Rochester, New York
› Author Affiliations
Further Information

Publication History

22 November 2019

06 January 2020

Publication Date:
02 March 2020 (online)

Also available at
    Permissions and Reprints

Abstract

As chemotherapy for colorectal cancer becomes effective for extending long-term survival, its liver metastases (colorectal cancer liver metastases [CRCLM]) are considered as the progression that best defines patient survival. Surgical resection is the most effective and only curative treatment for CRCLM. Although advancement in liver surgery to increase resectability of CRCLM has borne fruit, there are still limitations, namely tumor burden, remnant liver volume, and chemotherapy-related liver damage. CRCLM used to be considered a contraindication for liver transplantation (LTx) based on preliminary experience in the early era of LTx. Recent advancement in chemotherapy and surgical resection for CRCLM as well as improved outcome of LTx have attracted interest in revisiting this old dogma of LTx for CRCLM. Preliminary experience from Norway has shown promising results and potential for long-term survival with LTx. In this article, we review the history of LTx for CRCLM, rationale for revisiting the concept, early experience from Norway and discuss the issues around and future perspectives on LTx for CRCLM.

Keywords

colorectal cancer - liver metastases - liver transplantation
 

  • References

  • 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69 (01) 7-34
    CrossrefPubMedGoogle Scholar
  • 2 Kanas GP, Taylor A, Primrose JN. , et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012; 4 (01) 283-301
    PubMedGoogle Scholar
  • 3 de Jong MC, Pulitano C, Ribero D. , et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009; 250 (03) 440-448
    CrossrefPubMedGoogle Scholar
  • 4 Nordlinger B, Sorbye H, Glimelius B. , et al; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013; 14 (12) 1208-1215
    CrossrefPubMedGoogle Scholar
  • 5 Starzl TE, Fung JJ. Themes of liver transplantation. Hepatology 2010; 51 (06) 1869-1884
    CrossrefPubMedGoogle Scholar
  • 6 Kappel S, Kandioler D, Steininger R. , et al. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer. Transplantation 2006; 81 (01) 64-70
    CrossrefPubMedGoogle Scholar
  • 7 Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int 2008; 21 (12) 1107-1117
    CrossrefPubMedGoogle Scholar
  • 8 Foss A, Adam R, Dueland S. Liver transplantation for colorectal liver metastases: revisiting the concept. Transpl Int 2010; 23 (07) 679-685
    CrossrefPubMedGoogle Scholar
  • 9 Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. 1999; 230 (03) 309-318
    PubMedGoogle Scholar
  • 10 Kattan MW, Gönen M, Jarnagin WR. , et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008; 247 (02) 282-287
    CrossrefPubMedGoogle Scholar
  • 11 Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien P-A. Chemotherapy before liver resection of colorectal metastases: friend or foe?. Ann Surg 2012; 255 (02) 237-247
    CrossrefPubMedGoogle Scholar
  • 12 de Jong MC, Mayo SC, Pulitano C. , et al. Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 2009; 13 (12) 2141-2151
    CrossrefPubMedGoogle Scholar
  • 13 Malaguti P, Vari S, Cognetti F, Fabi A. The mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directions. 2013; 33 (01) 21-28
    PubMedGoogle Scholar
  • 14 Motzer RJ, Escudier B, Oudard S. , et al; RECORD-1 Study Group. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 2008; 372 (9637): 449-456
    CrossrefPubMedGoogle Scholar
  • 15 Cholongitas E, Mamou C, Rodríguez-Castro KI, Burra P. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int 2014; 27 (10) 1039-1049
    CrossrefPubMedGoogle Scholar
  • 16 Hagness M, Foss A, Line P-D. , et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg 2013; 257 (05) 800-806
    CrossrefPubMedGoogle Scholar
  • 17 Hecht JR, Mitchell E, Chidiac T. , et al. A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. J Clin Oncol 2009; 27 (05) 672-680
    CrossrefPubMedGoogle Scholar
  • 18 House MG, Ito H, Gönen M. , et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 2010; 210 (05) 744-752
    CrossrefPubMedGoogle Scholar
  • 19 Hagness M, Foss A, Egge TS, Dueland S. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg Oncol 2014; 21 (04) 1323-1329
    CrossrefPubMedGoogle Scholar
  • 20 Dueland S, Syversveen T, Solheim JM. , et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann Surg 2019; (June): 1-7
    PubMedGoogle Scholar
  • 21 Dueland S, Grut H, Syversveen T, Hagness M, Line P-D. Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis. Am J Transplant 2020; 20 (02) 530-537
    CrossrefPubMedGoogle Scholar
  • 22 Scortegagna Jr E, Karam AR, Sioshansi S, Bozorgzadeh A, Barry C, Hussain S. Hepatocellular carcinoma recurrence pattern following liver transplantation and a suggested surveillance algorithm. Clin Imaging 2016; 40 (06) 1131-1134
    CrossrefPubMedGoogle Scholar
  • 23 Hwang S, Kim Y-H, Kim DK. , et al. Resection of pulmonary metastases from hepatocellular carcinoma following liver transplantation. World J Surg 2012; 36 (07) 1592-1602
    CrossrefPubMedGoogle Scholar
  • 24 Au KP, Chok KSH. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: a proposed management algorithm. World J Gastroenterol 2018; 24 (45) 5081-5094
    CrossrefPubMedGoogle Scholar
  • 25 Grut H, Solberg S, Seierstad T. , et al. Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases. Br J Surg 2018; 105 (03) 295-301
    CrossrefPubMedGoogle Scholar
  • 26 Dueland S, Guren TK, Hagness M. , et al. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?. Ann Surg 2015; 261 (05) 956-960
    CrossrefPubMedGoogle Scholar
  • 27 Zheng Z, Liang W, Milgrom DP. , et al. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies. Transplantation 2014; 97 (02) 227-234
    CrossrefPubMedGoogle Scholar
  • 28 Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 2010; 101 (01) 47-53
    CrossrefPubMedGoogle Scholar
  • 29 Bellavance EC, Lumpkins KM, Mentha G. , et al. Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?. J Gastrointest Surg 2008; 12 (10) 1699-1708
    CrossrefPubMedGoogle Scholar